应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
ORIC Oric Pharmaceuticals Inc.
交易中 12-05 10:23:27 EST
11.39
+0.00
-0.04%
最高
11.95
最低
11.33
成交量
32.14万
今开
11.66
昨收
11.39
日振幅
5.43%
总市值
11.09亿
流通市值
6.91亿
总股本
9,739万
成交额
376.37万
换手率
0.53%
流通股本
6,066万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
Oric® Pharmaceuticals在2025年ESMO亚洲大会上宣布Enozertinib(Oric-114)关于EGFR非典型和EGFR外显子20非小细胞肺癌的最新口头报告
美股速递 · 12-04 05:02
Oric® Pharmaceuticals在2025年ESMO亚洲大会上宣布Enozertinib(Oric-114)关于EGFR非典型和EGFR外显子20非小细胞肺癌的最新口头报告
Oric Pharmaceuticals第三季度净收入为-3258.7万美元
投资观察 · 11-20
Oric Pharmaceuticals第三季度净收入为-3258.7万美元
Oric Pharmaceuticals公布根据纳斯达克上市规则5635(C)(4)的诱因授予
投资观察 · 11-20
Oric Pharmaceuticals公布根据纳斯达克上市规则5635(C)(4)的诱因授予
Oric® Pharmaceuticals宣布Oric-944 1B期临床试验剂量探索部分完成,并持续展现潜在的最佳疗效与安全性
美股速递 · 11-14
Oric® Pharmaceuticals宣布Oric-944 1B期临床试验剂量探索部分完成,并持续展现潜在的最佳疗效与安全性
Oric Pharmaceuticals, Inc.盘中异动 急速下挫5.01%
市场透视 · 08-09
Oric Pharmaceuticals, Inc.盘中异动 急速下挫5.01%
Oric Pharmaceuticals, Inc.盘中异动 股价大跌5.17%报9.47美元
市场透视 · 08-06
Oric Pharmaceuticals, Inc.盘中异动 股价大跌5.17%报9.47美元
Oric Pharmaceuticals, Inc.盘中异动 股价大跌5.04%
市场透视 · 08-01
Oric Pharmaceuticals, Inc.盘中异动 股价大跌5.04%
Oric Pharmaceuticals, Inc.盘中异动 股价大跌5.01%报10.62美元
市场透视 · 07-29
Oric Pharmaceuticals, Inc.盘中异动 股价大跌5.01%报10.62美元
Oric Pharmaceuticals, Inc.盘中异动 下午盘快速上涨5.23%
市场透视 · 07-11
Oric Pharmaceuticals, Inc.盘中异动 下午盘快速上涨5.23%
Oric Pharmaceuticals, Inc.盘中异动 早盘大幅拉升5.03%
市场透视 · 07-09
Oric Pharmaceuticals, Inc.盘中异动 早盘大幅拉升5.03%
Oric Pharmaceuticals, Inc.6月26日成交额为1819.04万美元
市场透视 · 06-27
Oric Pharmaceuticals, Inc.6月26日成交额为1819.04万美元
Oric Pharmaceuticals, Inc.6月24日成交额为1272.72万美元
市场透视 · 06-25
Oric Pharmaceuticals, Inc.6月24日成交额为1272.72万美元
Oric Pharmaceuticals, Inc.盘中异动 早盘股价大涨5.16%
市场透视 · 06-23
Oric Pharmaceuticals, Inc.盘中异动 早盘股价大涨5.16%
Oric Pharmaceuticals, Inc.6月20日成交额为1460.63万美元
市场透视 · 06-21
Oric Pharmaceuticals, Inc.6月20日成交额为1460.63万美元
Oric Pharmaceuticals, Inc.盘中异动 大幅上涨5.09%报9.49美元
市场透视 · 06-19
Oric Pharmaceuticals, Inc.盘中异动 大幅上涨5.09%报9.49美元
Oric Pharmaceuticals, Inc.盘中异动 大幅拉升5.01%报9.86美元
市场透视 · 06-13
Oric Pharmaceuticals, Inc.盘中异动 大幅拉升5.01%报9.86美元
Oric Pharmaceuticals, Inc.盘中异动 下午盘急速拉升5.15%
市场透视 · 06-10
Oric Pharmaceuticals, Inc.盘中异动 下午盘急速拉升5.15%
Oric Pharmaceuticals, Inc.盘中异动 早盘股价大跌5.25%
市场透视 · 03-10
Oric Pharmaceuticals, Inc.盘中异动 早盘股价大跌5.25%
Oric Pharmaceuticals, Inc.盘中异动 临近收盘快速下跌5.23%
市场透视 · 03-04
Oric Pharmaceuticals, Inc.盘中异动 临近收盘快速下跌5.23%
Oric Pharmaceuticals, Inc.盘中异动 临近收盘股价大跌5.06%
市场透视 · 02-28
Oric Pharmaceuticals, Inc.盘中异动 临近收盘股价大跌5.06%
加载更多
公司概况
公司名称:
Oric Pharmaceuticals Inc.
所属市场:
NASDAQ
上市日期:
--
主营业务:
ORIC Pharmaceuticals, Inc.在特拉华州注册,成立于2014年8月。该公司是临床阶段的生物制药公司,致力于通过克服癌症抵抗力来改善患者的生活。
发行价格:
--
{"stockData":{"symbol":"ORIC","market":"US","secType":"STK","nameCN":"Oric Pharmaceuticals Inc.","latestPrice":11.385,"timestamp":1764948206627,"preClose":11.39,"halted":0,"volume":321402,"delay":0,"floatShares":60659100,"shares":97389279,"eps":-1.69572,"marketStatus":"交易中","change":-0.005,"latestTime":"12-05 10:23:27 EST","open":11.66,"high":11.949,"low":11.33,"amount":3763681.7004,"amplitude":0.054346,"askPrice":11.42,"askSize":41,"bidPrice":11.34,"bidSize":101,"shortable":3,"etf":0,"ttmEps":-1.69572,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1764968400000},"marketStatusCode":2,"adr":0,"listingDate":1587700800000,"exchange":"NASDAQ","adjPreClose":11.39,"preHourTrading":{"tag":"盘前","latestPrice":11.75,"preClose":11.39,"latestTime":"09:24 EST","volume":4720,"amount":55325.6216,"timestamp":1764944661717},"postHourTrading":{"tag":"盘后","latestPrice":11.39,"preClose":11.39,"latestTime":"19:24 EST","volume":17614,"amount":200626.519,"timestamp":1764894295996},"volumeRatio":1.96285,"impliedVol":1.2672,"impliedVolPercentile":0.7},"requestUrl":"/m/hq/s/ORIC","defaultTab":"news","newsList":[{"id":"1117121799","title":"Oric® Pharmaceuticals在2025年ESMO亚洲大会上宣布Enozertinib(Oric-114)关于EGFR非典型和EGFR外显子20非小细胞肺癌的最新口头报告","url":"https://stock-news.laohu8.com/highlight/detail?id=1117121799","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1117121799?lang=zh_cn&edition=full","pubTime":"2025-12-04 05:02","pubTimestamp":1764795742,"startTime":"0","endTime":"0","summary":"Oric® Pharmaceuticals在2025年ESMO亚洲大会上宣布Enozertinib(Oric-114)关于EGFR非典型和EGFR外显子20非小细胞肺癌的最新口头报告。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ORIC"],"gpt_icon":0},{"id":"1128963466","title":"Oric Pharmaceuticals第三季度净收入为-3258.7万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1128963466","media":"投资观察","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1128963466?lang=zh_cn&edition=full","pubTime":"2025-11-20 01:45","pubTimestamp":1763574350,"startTime":"0","endTime":"0","summary":"11月13日 - Oric Pharmaceuticals第三季度运营支出为3667.1万美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ORIC","BK4139"],"gpt_icon":0},{"id":"1189416261","title":"Oric Pharmaceuticals公布根据纳斯达克上市规则5635(C)(4)的诱因授予","url":"https://stock-news.laohu8.com/highlight/detail?id=1189416261","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1189416261?lang=zh_cn&edition=full","pubTime":"2025-11-20 01:13","pubTimestamp":1763572428,"startTime":"0","endTime":"0","summary":"Oric Pharmaceuticals Inc. ::*ORIC PHARMACEUTICALS公布根据纳斯达克上市规则5635(C)(4)的诱因授予","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ORIC"],"gpt_icon":0},{"id":"1187798230","title":"Oric® Pharmaceuticals宣布Oric-944 1B期临床试验剂量探索部分完成,并持续展现潜在的最佳疗效与安全性","url":"https://stock-news.laohu8.com/highlight/detail?id=1187798230","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1187798230?lang=zh_cn&edition=full","pubTime":"2025-11-14 05:06","pubTimestamp":1763067973,"startTime":"0","endTime":"0","summary":"Oric® Pharmaceuticals宣布Oric-944 1B期临床试验的剂量探索部分已完成,并继续展现出潜在的最佳疗效与安全性。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ORIC"],"gpt_icon":0},{"id":"2558157942","title":"Oric Pharmaceuticals, Inc.盘中异动 急速下挫5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2558157942","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558157942?lang=zh_cn&edition=full","pubTime":"2025-08-09 01:46","pubTimestamp":1754675195,"startTime":"0","endTime":"0","summary":"北京时间2025年08月09日01时46分,Oric Pharmaceuticals, Inc.股票出现波动,股价急速跳水5.01%。Oric Pharmaceuticals, Inc.股票所在的生物技术行业中,整体跌幅为1.10%。其相关个股中,Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Hyperion Defi, Inc.、Alector, Inc.涨幅较大,Bioxcel Therapeutics, Inc.、Biovie Inc.、Onconetix, Inc.较为活跃,换手率分别为654.25%、172.55%、103.35%,振幅较大的相关个股有60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、180 Life Sciences Corp C/Wts 07/11/2025、Longeveron Inc.,振幅分别为75.81%、73.00%、49.61%。Oric Pharmaceuticals, Inc.公司简介:ORIC Pharmaceuticals Inc是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080901463594d831e4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080901463594d831e4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ORIC"],"gpt_icon":0},{"id":"2557303669","title":"Oric Pharmaceuticals, Inc.盘中异动 股价大跌5.17%报9.47美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557303669","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557303669?lang=zh_cn&edition=full","pubTime":"2025-08-06 22:26","pubTimestamp":1754490394,"startTime":"0","endTime":"0","summary":"北京时间2025年08月06日22时26分,Oric Pharmaceuticals, Inc.股票出现异动,股价急速下跌5.17%。Oric Pharmaceuticals, Inc.股票所在的生物技术行业中,整体跌幅为0.47%。其相关个股中,Bioxcel Therapeutics, Inc.、Biomx Inc.、诺瓦瓦克斯医药涨幅较大,Bioxcel Therapeutics, Inc.、Biomx Inc.、Psyence Biomedical Ltd.较为活跃,换手率分别为543.34%、344.06%、42.70%,振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Fortrea Holdings Inc.,振幅分别为45.15%、44.74%、32.09%。Oric Pharmaceuticals, Inc.公司简介:ORIC Pharmaceuticals Inc是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080622263494d3916f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080622263494d3916f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ORIC"],"gpt_icon":0},{"id":"2556830257","title":"Oric Pharmaceuticals, Inc.盘中异动 股价大跌5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2556830257","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556830257?lang=zh_cn&edition=full","pubTime":"2025-08-01 02:15","pubTimestamp":1753985728,"startTime":"0","endTime":"0","summary":"北京时间2025年08月01日02时15分,Oric Pharmaceuticals, Inc.股票出现波动,股价快速下挫5.04%。截至发稿,该股报10.17美元/股,成交量35.4136万股,换手率0.42%,振幅5.23%。Oric Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为1.94%。其相关个股中,Soligenix, Inc.、Silexion Therapeutics Corp、Jyong Biotech Ltd.涨幅较大,Soligenix, Inc.、Psyence Biomedical Ltd.、Onconetix, Inc.较为活跃,换手率分别为10925.06%、5110.42%、4875.21%,振幅较大的相关个股有Soligenix, Inc.、Silexion Therapeutics Corp、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 ,振幅分别为297.60%、97.88%、97.44%。Oric Pharmaceuticals, Inc.公司简介:ORIC Pharmaceuticals Inc是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250801021528a6cc1ec0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250801021528a6cc1ec0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ORIC"],"gpt_icon":0},{"id":"2555052683","title":"Oric Pharmaceuticals, Inc.盘中异动 股价大跌5.01%报10.62美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2555052683","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555052683?lang=zh_cn&edition=full","pubTime":"2025-07-29 21:44","pubTimestamp":1753796650,"startTime":"0","endTime":"0","summary":"北京时间2025年07月29日21时44分,Oric Pharmaceuticals, Inc.股票出现波动,股价大幅下挫5.01%。截至发稿,该股报10.62美元/股,成交量12.1247万股,换手率0.14%,振幅6.53%。Oric Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为0.06%。其相关个股中,Salarius Pharmaceuticals, Inc.、Surrozen Inc C/Wts 01/08/2031 、Scinai Immunotherapeutics Ltd涨幅较大,Scinai Immunotherapeutics Ltd、Salarius Pharmaceuticals, Inc.、Tnf Pharmaceuticals, Inc.较为活跃,换手率分别为3227.56%、1870.16%、1288.57%,振幅较大的相关个股有Salarius Pharmaceuticals, Inc.、Adial Pharmaceuticals, Inc、Scinai Immunotherapeutics Ltd,振幅分别为98.49%、45.70%、43.41%。Oric Pharmaceuticals, Inc.公司简介:ORIC Pharmaceuticals Inc是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072921441097258a9e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072921441097258a9e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ORIC"],"gpt_icon":0},{"id":"2550673612","title":"Oric Pharmaceuticals, Inc.盘中异动 下午盘快速上涨5.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2550673612","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550673612?lang=zh_cn&edition=full","pubTime":"2025-07-11 02:55","pubTimestamp":1752173736,"startTime":"0","endTime":"0","summary":"北京时间2025年07月11日02时55分,Oric Pharmaceuticals, Inc.股票出现异动,股价急速上涨5.23%。Oric Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为0.70%。其相关个股中,Q32 Bio Inc.、Pelthos Therapeutics Inc.、Lixte Biotechnology Holdings Inc C/Wts 30/11/2025 涨幅较大,Cognition Therapeutics, Inc.、Q32 Bio Inc.、Calidi Biotherapeutics, Inc.较为活跃,换手率分别为384.62%、358.42%、345.29%,振幅较大的相关个股有Seastar Medical Holding Corp C/Wts 28/10/2027 、Q32 Bio Inc.、Pelthos Therapeutics Inc.,振幅分别为91.19%、90.07%、85.25%。Oric Pharmaceuticals, Inc.公司简介:ORIC Pharmaceuticals Inc是一家临床阶段的生物制药公司。该公司的产品候选药物包括 ORIC-944、ORIC-114 和 ORIC-533。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250711025537a6a21c96&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250711025537a6a21c96&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ORIC"],"gpt_icon":0},{"id":"2550659986","title":"Oric Pharmaceuticals, Inc.盘中异动 早盘大幅拉升5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2550659986","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550659986?lang=zh_cn&edition=full","pubTime":"2025-07-09 22:54","pubTimestamp":1752072876,"startTime":"0","endTime":"0","summary":"北京时间2025年07月09日22时54分,Oric Pharmaceuticals, Inc.股票出现波动,股价快速上涨5.03%。Oric Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为1.20%。其相关个股中,Calidi Biotherapeutics, Inc.、Lixte Biotechnology Holdings Inc C/Wts 30/11/2025 、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 涨幅较大,Calidi Biotherapeutics, Inc.、Kazia Therapeutics Limited、Mustang Bio, Inc.较为活跃,换手率分别为1139.65%、713.28%、533.69%,振幅较大的相关个股有Calidi Biotherapeutics, Inc.、Lixte Biotechnology Holdings Inc C/Wts 30/11/2025 、Prokidney Corp.,振幅分别为173.13%、112.02%、59.79%。Oric Pharmaceuticals, Inc.公司简介:ORIC Pharmaceuticals Inc是一家临床阶段的生物制药公司。该公司的产品候选药物包括 ORIC-944、ORIC-114 和 ORIC-533。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709225436a4409994&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709225436a4409994&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ORIC"],"gpt_icon":0},{"id":"2546760973","title":"Oric Pharmaceuticals, Inc.6月26日成交额为1819.04万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2546760973","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546760973?lang=zh_cn&edition=full","pubTime":"2025-06-27 12:25","pubTimestamp":1750998327,"startTime":"0","endTime":"0","summary":"美东时间2025年6月26日,Oric Pharmaceuticals, Inc.成交额为1819.04万美元,成交额较昨日增加118.93%,当日成交量为173.98万股。Oric Pharmaceuticals, Inc.于2025年6月26日涨2.64%,报10.5美元,该股过去5个交易日涨13.88%,年初至今涨30.11%,过去60日涨88.17%。|近5个交易日成交情况||||#|日期|成交额(美元)|成交额较昨日变化|成交量(股)|#|2025-06-26|1819.04万|118.93%|173.98万|#|2025-06-25|830.86万|-34.72%|79.43万|#|2025-06-24|1272.72万|60.00%|119.73万|#|2025-06-23|795.46万|-45.54%|81.66万|#|2025-06-20|1460.63万|110.59%|157.14万|ORIC Pharmaceuticals Inc是一家临床阶段的生物制药公司。该公司的产品候选药物包括 ORIC-944、ORIC-114 和 ORIC-533。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250627122532a4c04ae4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250627122532a4c04ae4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ORIC"],"gpt_icon":0},{"id":"2546464264","title":"Oric Pharmaceuticals, Inc.6月24日成交额为1272.72万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2546464264","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546464264?lang=zh_cn&edition=full","pubTime":"2025-06-25 12:38","pubTimestamp":1750826323,"startTime":"0","endTime":"0","summary":"美东时间2025年6月24日,Oric Pharmaceuticals, Inc.成交额为1272.72万美元,成交额较昨日增加60.00%,当日成交量为119.73万股。Oric Pharmaceuticals, Inc.于2025年6月24日涨4.9%,报10.49美元,该股过去5个交易日涨11.48%,年初至今涨29.99%,过去60日涨66.77%。|近5个交易日成交情况||||#|日期|成交额(美元)|成交额较昨日变化|成交量(股)|#|2025-06-24|1272.72万|60.00%|119.73万|#|2025-06-23|795.46万|-45.54%|81.66万|#|2025-06-20|1460.63万|110.59%|157.14万|#|2025-06-18|693.58万|-6.33%|74.92万|#|2025-06-17|740.48万|-22.82%|80.85万|ORIC Pharmaceuticals Inc是一家临床阶段的生物制药公司。该公司的产品候选药物包括 ORIC-944、ORIC-114 和 ORIC-533。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250625123852a4bc9fce&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250625123852a4bc9fce&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ORIC","BK4139"],"gpt_icon":0},{"id":"2545448040","title":"Oric Pharmaceuticals, Inc.盘中异动 早盘股价大涨5.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2545448040","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2545448040?lang=zh_cn&edition=full","pubTime":"2025-06-23 22:42","pubTimestamp":1750689777,"startTime":"0","endTime":"0","summary":"北京时间2025年06月23日22时42分,Oric Pharmaceuticals, Inc.股票出现异动,股价大幅上涨5.16%。截至发稿,该股报9.79美元/股,成交量13.66万股,换手率0.16%,振幅6.66%。Oric Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为0.21%。其相关个股中,Indaptus Therapeutics, Inc.、Cidara Therapeutics, Inc.、Vor Biopharma Inc.涨幅较大,Indaptus Therapeutics, Inc.、Nucana Plc、Eyenovia, Inc.较为活跃,换手率分别为1503.70%、546.52%、312.04%,振幅较大的相关个股有Immatics N V C/Wts 01/07/2025 、Indaptus Therapeutics, Inc.、Nls Pharmaceutics Ltd C/Wts 02/02/2026,振幅分别为71.02%、64.31%、57.53%。Oric Pharmaceuticals, Inc.公司简介:ORIC Pharmaceuticals Inc是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250623224257a719165e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250623224257a719165e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ORIC"],"gpt_icon":0},{"id":"2545102714","title":"Oric Pharmaceuticals, Inc.6月20日成交额为1460.63万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2545102714","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2545102714?lang=zh_cn&edition=full","pubTime":"2025-06-21 12:34","pubTimestamp":1750480492,"startTime":"0","endTime":"0","summary":"美东时间2025年6月20日,Oric Pharmaceuticals, Inc.成交额为1460.63万美元,成交额较昨日增加110.59%,当日成交量为157.14万股。Oric Pharmaceuticals, Inc.于2025年6月20日涨0.98%,报9.31美元,该股过去5个交易日跌3.72%,年初至今涨15.37%,过去60日涨37.93%。|近5个交易日成交情况||||#|日期|成交额(美元)|成交额较昨日变化|成交量(股)|#|2025-06-20|1460.63万|110.59%|157.14万|#|2025-06-18|693.58万|-6.33%|74.92万|#|2025-06-17|740.48万|-22.82%|80.85万|#|2025-06-16|959.46万|41.21%|101.13万|#|2025-06-13|679.47万|-12.98%|71.41万|ORIC Pharmaceuticals Inc是一家临床阶段的生物制药公司。该公司的产品候选药物包括 ORIC-944、ORIC-114 和 ORIC-533。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250621123453a7159d21&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250621123453a7159d21&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ORIC","BK4139"],"gpt_icon":0},{"id":"2544901028","title":"Oric Pharmaceuticals, Inc.盘中异动 大幅上涨5.09%报9.49美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2544901028","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544901028?lang=zh_cn&edition=full","pubTime":"2025-06-19 00:35","pubTimestamp":1750264504,"startTime":"0","endTime":"0","summary":"北京时间2025年06月19日00时35分,Oric Pharmaceuticals, Inc.股票出现异动,股价快速上涨5.09%。截至发稿,该股报9.49美元/股,成交量36.0377万股,换手率0.42%,振幅6.98%。Oric Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为0.71%。其相关个股中,Aptevo Therapeutics Inc.、Immuneering Corporation、Caris Life Sciences Inc涨幅较大,Aptevo Therapeutics Inc.、Biodexa Pharmaceuticals Plc、Nucana Plc较为活跃,换手率分别为16208.70%、1023.14%、654.31%,振幅较大的相关个股有Aptevo Therapeutics Inc.、Immatics N V C/Wts 01/07/2025 、Liminatus Pharma Inc C/Wts 30/04/2030 ,振幅分别为294.68%、97.75%、60.00%。Oric Pharmaceuticals, Inc.公司简介:ORIC Pharmaceuticals Inc是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250619003504a710dc10&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250619003504a710dc10&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ORIC"],"gpt_icon":0},{"id":"2543549069","title":"Oric Pharmaceuticals, Inc.盘中异动 大幅拉升5.01%报9.86美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2543549069","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2543549069?lang=zh_cn&edition=full","pubTime":"2025-06-13 01:29","pubTimestamp":1749749362,"startTime":"0","endTime":"0","summary":"北京时间2025年06月13日01时29分,Oric Pharmaceuticals, Inc.股票出现异动,股价快速拉升5.01%。Oric Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为0.61%。其相关个股中,Klotho Neurosciences Inc C/Wts 21/06/2029 、Liminatus Pharma Inc C/Wts 30/04/2030 、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大,Nucana Plc、Polyrizon Ltd.、Klotho Neurosciences, Inc.较为活跃,换手率分别为2698.92%、812.97%、353.26%,振幅较大的相关个股有Klotho Neurosciences Inc C/Wts 21/06/2029 、Liminatus Pharma Inc C/Wts 30/04/2030 、Liminatus Pharma, Inc.,振幅分别为256.24%、169.83%、87.67%。Oric Pharmaceuticals, Inc.公司简介:ORIC Pharmaceuticals Inc是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250613012923977cea38&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250613012923977cea38&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ORIC"],"gpt_icon":0},{"id":"2542325593","title":"Oric Pharmaceuticals, Inc.盘中异动 下午盘急速拉升5.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2542325593","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542325593?lang=zh_cn&edition=full","pubTime":"2025-06-10 02:59","pubTimestamp":1749495576,"startTime":"0","endTime":"0","summary":"北京时间2025年06月10日02时59分,Oric Pharmaceuticals, Inc.股票出现波动,股价快速拉升5.15%。截至发稿,该股报9.80美元/股,成交量74.8521万股,换手率1.05%,振幅8.80%。Oric Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为1.69%。其相关个股中,Klotho Neurosciences, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 、Citius Pharmaceuticals, Inc.涨幅较大,Nucana Plc、Synaptogenix, Inc.、Klotho Neurosciences, Inc.较为活跃,换手率分别为16798.47%、3110.81%、3055.87%,振幅较大的相关个股有Klotho Neurosciences Inc C/Wts 21/06/2029 、Klotho Neurosciences, Inc.、Citius Pharmaceuticals, Inc.,振幅分别为673.58%、582.93%、175.09%。Oric Pharmaceuticals, Inc.公司简介:ORIC Pharmaceuticals Inc是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506100259369515242b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506100259369515242b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ORIC"],"gpt_icon":0},{"id":"2518755942","title":"Oric Pharmaceuticals, Inc.盘中异动 早盘股价大跌5.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518755942","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518755942?lang=zh_cn&edition=full","pubTime":"2025-03-10 22:31","pubTimestamp":1741617117,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日22时31分,Oric Pharmaceuticals, Inc.股票出现波动,股价快速下挫5.25%。截至发稿,该股报7.58美元/股,成交量7.5166万股,换手率0.11%,振幅3.63%。Oric Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为0.08%。其相关个股中,Checkpoint Therapeutics, Inc.、Mineralys Therapeutics, Inc.、Aeon Biopharma, Inc.涨幅较大,Biodexa Pharmaceuticals Plc、Scisparc Ltd.、Aeon Biopharma, Inc.较为活跃,换手率分别为3460.23%、733.65%、526.63%,振幅较大的相关个股有Dogwood Therapeutics, Inc.、Biodexa Pharmaceuticals Plc、Scisparc Ltd.,振幅分别为41.36%、40.33%、40.24%。Oric Pharmaceuticals, Inc.公司简介:ORIC Pharmaceuticals Inc是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310223157a26a3bd5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310223157a26a3bd5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ORIC"],"gpt_icon":0},{"id":"2516631766","title":"Oric Pharmaceuticals, Inc.盘中异动 临近收盘快速下跌5.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516631766","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516631766?lang=zh_cn&edition=full","pubTime":"2025-03-04 04:41","pubTimestamp":1741034475,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日04时41分,Oric Pharmaceuticals, Inc.股票出现异动,股价快速跳水5.23%。Oric Pharmaceuticals, Inc.股票所在的生物技术行业中,整体跌幅为0.29%。其相关个股中,Abpro Holdings Inc C/Wts 12/11/2029 、Cardio Diagnostics Holdings Inc C/Wts To Pur Com、Celularity Inc C/Wts 16/07/2026 涨幅较大,Allarity Therapeutics, Inc.、Entero Therapeutics Inc.、Aeon Biopharma, Inc.较为活跃,换手率分别为215.94%、187.94%、164.66%,振幅较大的相关个股有Radiopharm Theranostics Limited、Entero Therapeutics Inc.、Celularity Inc C/Wts 16/07/2026 ,振幅分别为119.50%、70.53%、64.88%。Oric Pharmaceuticals, Inc.公司简介:ORIC Pharmaceuticals Inc是一家临床阶段的生物制药公司。该公司的产品候选药物包括 ORIC-944、ORIC-114 和 ORIC-533。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304044115989a61a1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304044115989a61a1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ORIC"],"gpt_icon":0},{"id":"2514330533","title":"Oric Pharmaceuticals, Inc.盘中异动 临近收盘股价大跌5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514330533","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514330533?lang=zh_cn&edition=full","pubTime":"2025-02-28 04:55","pubTimestamp":1740689725,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日04时55分,Oric Pharmaceuticals, Inc.股票出现波动,股价急速下跌5.06%。截至发稿,该股报7.88美元/股,成交量67.988万股,换手率0.96%,振幅8.43%。Oric Pharmaceuticals, Inc.股票所在的生物技术行业中,整体跌幅为0.59%。其相关个股中,Pepgen Inc.、Ibio, Inc.、Cingulate Inc C/Wts 10/12/2026 涨幅较大,Quoin Pharmaceuticals Ltd、Aeon Biopharma, Inc.、Vincerx Pharma, Inc.较为活跃,换手率分别为1954.27%、423.50%、197.98%,振幅较大的相关个股有Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Pepgen Inc.、Pds Biotechnology Corporation,振幅分别为86.14%、67.32%、55.84%。Oric Pharmaceuticals, Inc.公司简介:ORIC Pharmaceuticals Inc是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228045526abdfc290&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228045526abdfc290&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ORIC"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.oricpharma.com","stockEarnings":[{"period":"1week","weight":-0.0364},{"period":"1month","weight":-0.074},{"period":"3month","weight":0.0469},{"period":"6month","weight":0.2221},{"period":"1year","weight":0.1622},{"period":"ytd","weight":0.4114}],"compareEarnings":[{"period":"1week","weight":0.0069},{"period":"1month","weight":0.0136},{"period":"3month","weight":0.0574},{"period":"6month","weight":0.1423},{"period":"1year","weight":0.1263},{"period":"ytd","weight":0.1677}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"ORIC Pharmaceuticals, Inc.在特拉华州注册,成立于2014年8月。该公司是临床阶段的生物制药公司,致力于通过克服癌症抵抗力来改善患者的生活。","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":-0.002864},{"month":2,"riseRate":0.4,"avgChangeRate":-0.079553},{"month":3,"riseRate":0.4,"avgChangeRate":-0.098966},{"month":4,"riseRate":0.2,"avgChangeRate":-0.164176},{"month":5,"riseRate":0.666667,"avgChangeRate":0.07899},{"month":6,"riseRate":0.666667,"avgChangeRate":0.141043},{"month":7,"riseRate":0.333333,"avgChangeRate":-0.000511},{"month":8,"riseRate":0.666667,"avgChangeRate":0.090659},{"month":9,"riseRate":0.166667,"avgChangeRate":-0.048915},{"month":10,"riseRate":0.333333,"avgChangeRate":-0.0811},{"month":11,"riseRate":0.666667,"avgChangeRate":0.167402},{"month":12,"riseRate":0.5,"avgChangeRate":0.106584}],"exchange":"NASDAQ","name":"Oric Pharmaceuticals Inc.","nameEN":"Oric Pharmaceuticals Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.9","shortVersion":"4.35.9","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Oric Pharmaceuticals Inc.(ORIC)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Oric Pharmaceuticals Inc.(ORIC)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Oric Pharmaceuticals Inc.,ORIC,Oric Pharmaceuticals Inc.股票,Oric Pharmaceuticals Inc.股票老虎,Oric Pharmaceuticals Inc.股票老虎国际,Oric Pharmaceuticals Inc.行情,Oric Pharmaceuticals Inc.股票行情,Oric Pharmaceuticals Inc.股价,Oric Pharmaceuticals Inc.股市,Oric Pharmaceuticals Inc.股票价格,Oric Pharmaceuticals Inc.股票交易,Oric Pharmaceuticals Inc.股票购买,Oric Pharmaceuticals Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Oric Pharmaceuticals Inc.(ORIC)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Oric Pharmaceuticals Inc.(ORIC)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}